FINAL ANALYSIS OF ACT III: A PHASE II TRIAL OF PF-04948568 (CDX-110) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

被引：0

作者：

Lai, Rose K. ^{[1
]}

Recht, Lawrence D. ^{[2
]}

Reardon, David A. ^{[3
]}

Paleologos, Nina ^{[4
]}

Groves, Morris ^{[5
]}

Rosenfeld, Myrna R. ^{[6
]}

Meech, Sandra

Davis, Tom

Pavlov, Dmitri

Marshall, Margaret A.

Sampson, John

机构：

[1] Columbia Univ, Neurol Inst, New York, NY 10027 USA

[2] Stanford Canc Ctr, Stanford, CA USA

[3] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27706 USA

[4] NorthShore Univ Hlth Syst, Evanston Hosp, Evanston, IL USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[6] Hosp Univ Penn, Philadelphia, PA 19104 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：76 / 77

页数：2